urethane has been researched along with HIV in 2 studies
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Randolph, JT | 1 |
| DeGoey, DA | 1 |
| Hammer, K | 1 |
| Hatlelid, J | 1 |
| Grøtli, M | 1 |
| Arukwe, J | 1 |
| Klaveness, J | 1 |
| Rise, F | 1 |
| Undheim, K | 1 |
1 review available for urethane and HIV
| Article | Year |
|---|---|
Peptidomimetic inhibitors of HIV protease.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; Dipeptides; Furans; HIV; | 2004 |
1 other study available for urethane and HIV
| Article | Year |
|---|---|
Ether, carbonate and urethane deoxynucleoside derivatives as prodrugs.
Topics: Antiviral Agents; Carbonates; Deoxyribonucleosides; Drug Stability; Ethers; HIV; Prodrugs; Solubilit | 1996 |